TY - JOUR
T1 - Erythromycin ototoxicity
T2 - A call to heighten recognition
AU - Whitener, C. J.
AU - Parker, J. E.
AU - Lapp, N. L.
PY - 1991
Y1 - 1991
N2 - Bilateral sensorineural hearing loss developed in a 64-year-old woman treated with intravenous erythromycin lactobionate for bacteremic pneumococcal pneumonia. Discontinuance of the antibiotic led to prompt correction of the hearing deficit. Reversible hearing loss is an infrequently described adverse effect attributed to high-dose erythromycin therapy. Possible risk factors, including age, gender, and hepatic and renal function, may contribute to the development of erythromycin ototoxicity.
AB - Bilateral sensorineural hearing loss developed in a 64-year-old woman treated with intravenous erythromycin lactobionate for bacteremic pneumococcal pneumonia. Discontinuance of the antibiotic led to prompt correction of the hearing deficit. Reversible hearing loss is an infrequently described adverse effect attributed to high-dose erythromycin therapy. Possible risk factors, including age, gender, and hepatic and renal function, may contribute to the development of erythromycin ototoxicity.
UR - http://www.scopus.com/inward/record.url?scp=0026068078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026068078&partnerID=8YFLogxK
U2 - 10.1097/00007611-199110000-00013
DO - 10.1097/00007611-199110000-00013
M3 - Article
C2 - 1925722
AN - SCOPUS:0026068078
SN - 0038-4348
VL - 84
SP - 1214
EP - 1216
JO - Southern Medical Journal
JF - Southern Medical Journal
IS - 10
ER -